Clinical Trial: A Phase III Clinical Study on the Efficacy and Safety of HRS-1780 in the Treatment of Patients With Chronic Kidney Disease

U.S., Feb. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07419828) titled 'A Phase III Clinical Study on the Efficacy and Safety of HRS-1780 in the Treatment of Patients With Chronic Kidney Disease' on Feb. 12.

Brief Summary: The study is a Phase III clinical trial to evaluate the superiority of HRS-1780 tablets compared with placebo in delaying renal function decline in participants with chronic kidney disease (CKD) on the basis of standard treatment.

Study Start Date: March, 2026

Study Type: INTERVENTIONAL

Condition: Chronic Kidney Disease

Intervention: DRUG: HRS-1780 tablets

Oral tablets

DRUG: Placebo

Oral tablets

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Shandong Suncadia Medicine Co.,...